A trial fibrillation (AF) is an independent risk factor for stroke. Survivors of a stroke with AF have a high risk for recurrent stroke. 1 Oral anticoagulation using vitamin K antagonists or novel oral anticoagulants is highly effective for prevention of stroke in these patients.
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Because of chance variations in smaller series and different technologies for detection of undiagnosed AF, the diagnostic yield in these studies varies from 0% to 20%, [9] [10] [11] (Table 1 ) and the cost-effectiveness of prolonged ECG monitoring has been questioned. 12 Limited patient size (maximum number of patients, 425), but more importantly, custom-made ECG detection algorithms or specific ECG analyses, and singlecenter protocols render the published findings difficult to implement into routine care. To better define the diagnostic yield of prolonged ECG monitoring for the diagnosis of undiagnosed AF after a stroke, we performed a prospective multicenter cohort study of prolonged ECG monitoring using standard Holter ECG recorders in an unselected population of stroke or transient ischemic attack (TIA) survivors.
Subjects and Methods

Patients and Procedures
We aimed to include all consecutive patients admitted with stroke or TIA in 9 German secondary and tertiary stroke centers between May 2010 and January 2011. All patients with the clinical diagnosis of stroke or TIA underwent diagnostic workup as inpatients for ≥3 days as standard of care of patients with stroke following the guidelines of the European Stroke Organization 13 and the German Stroke Society. 14 To ensure comparable treatment standards within the entire study group, only centers with a certified stroke unit according to strictly 15 enforced by regular external audits, participated in the study. Inpatient evaluation of both patients with stroke and TIA is part of this standard. The diagnosis of TIA was based on clinical grounds and differentiated in a second step by presence or absence of ischemic lesion in computerized tomography (CT) or magnetic resonance imaging (MRI) following current definitions of stroke. 16 We excluded patients <18 years, patients with known AF or documented AF on admission, patients carrying a pacemaker with an atrial lead, patients who were unable or unwilling to give informed consent, and patients with life expectancy <1 year. Patients who were found not to have a stroke or TIA (stroke mimics) were later excluded from further evaluation.
The study complied with the Declaration of Helsinki. The protocol was approved by the Independent Ethics Committee of the Ärztekammer Westfalen-Lippe and University of Münster, Germany, and by all local ethics boards. All patients or their legal representatives gave their written informed consent.
Data Collection and Clinical Evaluation
Baseline characteristics were recorded on a standardized questionnaire, including a detailed medical history and baseline medication. Stroke severity was assessed using the modified Rankin Scale (mRS) 17 and the National Institutes of Health Stroke Scale (NIH-SS) 18 by video-trained physicians. 19 Findings of CT and MRI were evaluated for multiple lesions 20 and by the Alberta Stroke Program Early CT Score (ASPECTS). 21 Vascular evaluation included neurosonological assessment and echocardiographic assessment of left atrial size.
All patients underwent 72-hour Holter ECG monitoring initiated within 12 hours after hospital admission using a commercially available 3-lead Holter monitor device (Lifecard CF, Spacelabs Healthcare, Issaquah, WA), which was provided to all centers for the study. ECG recordings were analyzed in a central core laboratory (Institut für Klinisch-Kardiovaskuläre Forschung, IKKF GmbH, Munich, Germany) by 2 independent investigators blinded to clinical data using dedicated analysis software (Pathfinder, Software Version 8.701, Spacelabs Healthcare GmbH, Nürnberg, Germany). All Holter ECG recordings with suspected AF were subsequently evaluated by another independent observer (P. Kirchhof.). To further validate the correct Holter ECG analysis, 100 randomly selected Holter ECG recordings were reanalyzed by another investigator (R. Wachter). When previously undiagnosed AF was detected, the patient's physician was informed.
Pathogenesis of stroke was classified by Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. 22 Functional disability before onset of acute stroke symptoms and on discharge was rated using the mRS 17 and the Barthel Index (BI) 172. 23 Favorable outcome was defined as a score of 0 or 1 on the mRS and a score of 95 or 100 on the BI. Quality of life was determined by the EuroQol 5 Dimension 3 level questionnaire (EQ-5D-3 L) consisting of the EQ-5D and the EQ visual analog scale (EQ-VAS).
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Definitions and Statistical Analyses
AF was defined as ≥1 period of >30 seconds duration of an absolute arrhythmia without detectable P-waves and without a pattern more consistent with an alternative diagnosis. 25, 26 We did not discriminate atrial flutter and AF 27 because both arrhythmias carry a similar stroke risk and often coincide. Continuous data are given as median, range, and SD. Categorical variables are given as absolute number and percentage. Wilcoxon test (continuous variables) and Fischer exact test (categorical variables) were used to compare groups. Significance was assumed when the 2-sided probability value was <0.05, and probability values <0.001 were not further specified. A multivariate analysis was performed using logistic regression. All factors that associated with unknown AF in univariate analysis were included. To assess the added value of 72-hour Holter monitoring compared with the current standard of 24-hour Holter ECG, we determined detection rates for the 0-to 24-hour and for the 25-to 72-hour intervals. For calculation of 95% confidence interval (CI), binominal distribution was assumed. Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS, version 19), multivariate analysis using SAS version 9.2 (SAS Institute Inc, Cary, NC). Kaplan-Meier curves were generated using Prism 5 for Windows, version 5.0.3.
Results
Patient Population
During the study period (May 2010-January 2011), 7174 patients with stroke or TIA were admitted to the participating stroke units. A total of 1508 patients (21%) were excluded because of AF that was either known before the index event or documented on admission. Of the 5666 remaining patients, 1183 patients consented to participate in the study. Clinical and Holter data from 1135 patients were of sufficient quality for further statistical analysis (per protocol analysis; Figure 1 ). Clinical characteristics of the study population are given in Table 2 .
Median interval from onset of symptoms to start of Holter recording was 1 day (range 0-2 days) and always on the day after onset of stroke symptoms. Prolonged Holter monitoring was well tolerated, yielding a median ECG recording of 73 hours (range, 1-134 days) monitored time. Because of artifacts, interruptions for clinical procedures, and early detachment of the monitoring leads by patients, 926 patients (89%) had analyzable recordings of ≥60 hours. Adverse events in association with Holter ECG were not reported. 
Detection of Atrial Fibrillation
Clinical and Imaging Characteristics of Patients With Silent Atrial Fibrillation
Patients with otherwise undiagnosed AF were older and had less functional disability before the index stroke compared with patients without AF ( Table 2 ). The affected vascular territories were not different in patients with or without AF nor were multiple infarctions more common in either group (Table 3) . Evaluation of CT and MRI data (Table 3 ) revealed no clear preference of vascular territory in patients with sinus rhythm as compared to patients with undiagnosed AF. Patients with otherwise undiagnosed AF had more severe neurological deficits, and more often required inpatient poststroke care than patients without AF (Table 4) . Patients with AF more often received thrombolytic treatment (39% versus 12%; P<0.001; 
6028).
There were no statistically significant differences between patients with AF detected within 24 hours. (n=29) and patients with AF detected after 24 hours (n=20) for stroke severity on admission (NIH-SS), stroke pathogenesis according to the TOAST criteria, BI at discharge and place of discharge.
Discussion
Main Findings
This prospective multicenter study provides solid evidence that a prolonged 72-hour Holter ECG monitoring, integrated into routine inpatient stroke care, markedly increases the detection of AF compared with the current standard of care (24-hour Holter monitoring) in an unselected prospective cohort of >1000 patients recruited from 9 large stroke units. The prospective design and the participation of accredited and quality-controlled stroke units ensured a high standard of care in the participating hospitals. Such a simple extension of
Holter monitoring periods will identify further patients who benefit from oral anticoagulation, 2 while most other patients with stroke benefit from antiplatelet therapy. Hence, prolonged Holter ECG monitoring will directly change secondary prevention therapy in patients with previously unknown, Holter-documented AF.
Diagnostic Yield of Prolonged 72-Hour ECG Monitoring
Several single-center reports (Table 1) described various methods of intensified ECG monitoring to detect otherwise undiagnosed AF. However, most of the previous studies of prolonged ECG monitoring were single-center surveys and often used retrospective or investigational protocols, including implantation of invasive ECG monitors. Therefore, these pilot observations did not alter current recommendations for the diagnosis of AF in survivors of a stroke, which still recommend 24 hours of Holter ECG. 13 By simply extending the duration of Holter ECG recording to 72 hours, the number of stroke survivors in whom AF was detected nearly doubled in this study. Almost all currently available Holter monitoring systems are capable of 72 hours of monitoring. Furthermore, 72-hour monitoring seems feasible in most healthcare settings because patients with stroke are usually managed as inpatients for at least three days, allowing implementation of the prolonged monitoring without changes in care pathways. Thus, the monitoring pattern used in the present study could easily be implemented into routine care. It is likely that even longer ECG monitoring periods would identify further patients with undiagnosed AF (Table 1) . 28 Further studies are warranted to study the value of such a prolonged monitoring period. Unlike previous registries, the diagnosis of AF was adjudicated centrally by a core laboratory in this study, and validated by an independent, second ECG analysis. We detected AF in 4.3% (49 out of 1135) analyzable patients, approximately in the range of previous, smaller, single-center studies. 29, 30 The core laboratory evaluation altered the initial diagnosis in a few Holter ECGs, illustrating the need to carefully analyze ECG recordings before the diagnosis AF is made. On the contrary, a simple reading (as in the first step of our core laboratory evaluation) yielded a correct diagnosis of AF in >90% of patients, and our detection rates are in line with published rates (Table 1) .
Characteristics of Stroke Patients With AF
Patients with AF were older and had more severe neurological deficits than those without AF, consistent with previous data in patients with AF diagnosed by standard workup. A history of smoking and of dyslipidemia was more common in patients without AF, compatible with an atherosclerotic cause of stroke in these patients. 31 Interestingly, the imaging findings considered typical for cardioembolic stroke were not more common in patients with AF in this study. In contrast, previous studies revealed a particular embolic pattern in CT or MRI in case of proven embolic source. 32 It is conceivable that multiple lesions are a feature of long-lasting AF that is more likely to be detected by routine monitoring rather than early onset or paroxysmal AF, which was the most common pattern of AF in our cohort. A relevant proportion of patients on whom we found previously undiagnosed AF were classified as large-artery arteriosclerosis (22%) based on imaging of carotid vessels either by CT or MRI angiography or by means of color-coded Doppler ultrasound, comparable with smaller earlier reports. 33 This suggests the presence of multiple, competing causes for a stroke in these patients. Considering the ongoing discussion, 34 our data underline the importance of thorough screening for the presence of AF in all survivors of a stroke or TIA, rather than only in those whose clinical presentation suggests AF, for example, based on the TOAST classification. Based on our observations, prolonged ECG monitoring should be considered in all stroke patients without known AF, including patients with concurrent stroke causes such as carotid stenosis or small-artery disease.
Cost-Effectiveness
The effort of prolonged ECG monitoring seems cost-effective in this study: 1 week of outpatient monitoring with an assumed detection rate of 4.4% for otherwise undiagnosed AF was recently calculated to cost ≤$13 000 per quality-adjusted life-year, 12 depending on the additional drug treatment considered in the calculation. 35 Because our detection rate was comparable (4.3% [95% CI, 3.4%-5.2%]) to the abovementioned calculation while requiring less resources (3 instead of 7 days 
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December 2013 ECG monitoring), the cost per gain in quality-adjusted lifeyears will be equal or less. Also, as explained above, the monitoring scheme evaluated here can easily be incorporated into current stroke care pathways. Emerging techniques such as semiautomated analysis of ECG telemetry monitors on stroke units 36 could further facilitate detection of AF in the future.
Conclusions
This large prospective, multicenter study demonstrates that integrating a prolonged 72-hour ECG monitoring into a standardized diagnostic and therapeutic assessment protocol improves detection of previously undiagnosed AF in survivors of a stroke or TIA. The monitoring applied here can be implemented in a routine care pathway. The number needed to screen was reasonably small, and the effect on therapy decisions was already detectable on hospital discharge by higher use of oral anticoagulation. Prolonged ECG 
